← Leaderboards
Steven Paul Jenkins
Q2i, Llc
$1,657,101
Attributed
$1,657,101
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $837.8K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,657,101 · 1
By mechanism
R42$1,657,101 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Abstinence”
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- Susan Zief · Mathematica Inc.$8,271,888
- Miriam Komaromy · Rand Corporation$6,556,702
- Jamie Elizabeth Newman · Research Triangle Institute$5,937,082
Research focus
AbstinenceAchievementAcquired Immunodeficiency SyndromeAddictionAdherenceAmericasAreaArtificial IntelligenceBehavioralBeliefBusinessesCare ProvidersCaringCessation Of LifeClinicClinical ManagementCommercializationComputer SoftwareContinuity Of Patient CareCostCost SavingsCustomDashboardDesign
Grant awards (3)
Technology Improving Success of Medication-Assisted Treatment in Primary Care$594,298
R42 · FY2021 · DA · contact PI
Technology Improving Success of Medication-Assisted Treatment in Primary Care$837,803
R42 · FY2020 · DA · contact PI
Technology Improving Success of Medication-Assisted Treatment in Primary Care$225,000
R42 · FY2019 · DA · contact PI